|By Business Wire||
|June 2, 2014 10:01 AM EDT||
Esaote, one of the world’s leading medical imaging manufacturers, has launched a new global website – www.esaote.com. The site represents an entirely new customer experience and is the highlight of many new innovations aimed at supporting clinicians and corporate customers across the globe.
The website launch comes a year after the appointment of Esaote’s new CEO, Carlos Alonso. “The global market for medical imaging is evolving fast,” said Mr Alonso. “Innovation means ever greater potential for imaging across the clinical setting – not just as a diagnostic tool but also for clinical intervention and real-time follow-up.
“Building on Esaote’s reputation for technological innovation and quality, we have recently undergone a significant reorganisation of the business as we commit to putting the customer at the centre of everything we do.”
“Our new website demonstrates the commitment to succeed in a global market place. Through it we can better provide clinicians and corporate customers with the resources and clinical solutions they need.”
Esaote targets an acceleration of market share within US, China and key European markets, whilst also making key investments in growth markets such as the Nordics, Australia and South America. Key markets can expect local language versions of the new website to go live throughout summer 2014.
The new site has been built on an entirely new platform. Optimised for a fast and responsive user experience on any device from desktop to smart-phone, the site quickly leads the browser to a wealth of relevant content.
With €325.3 million consolidated sales in 2012 (of which 70% were generated from international markets), Esaote Group is a leading player in the biomedical equipment sector, with a particular focus on ultrasound, dedicated magnetic resonance, and software for managing the diagnostic process. Esaote has over 1,360 employees, 20% of which are employed in R&D activities. Esaote has industrial and research units in Italy (Genoa, Florence, Naples), the Netherlands (Maastricht) and China (Shenzhen). Esaote is internationally recognised as one of the “Top Ten” diagnostic imaging companies in the world and enjoys the co-operation of worldwide scientific and clinical research centres and universities. Esaote has filed more than120 international patents to date. Information about the Esaote Group and its products is available at www.esaote.com